Skip to content

Chemours CC Additional Paid-In Capital

Additional Paid-In Capital at other companies

Eastman Chemical logo
Eastman ChemicalEMN
$2.52B+1.8%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$38.85B-18.7%
Element Solutions logo
Element SolutionsESI
$4.29B+1.6%
Cabot Corporation logo
Cabot CorporationCBT
$1M-95.8%
Avient logo
AvientAVNT
$1.54B+0.3%
Westlake logo
WestlakeWLK
$685M+5.4%

Other financials

Income statement

See full
Revenue$1.4B+1.0%
Gross profit$212.0M-10.2%
Net income-$29.0M-480%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$563.0M+21.3%
Total debt$4.4B0.0%
Total equity$215.0M-62.0%
Total assets$7.3B-1.5%

Cash flow

See full
Operating cash flow-$44.0M+60.7%
CapEx$49.0M-41.7%
Free cash flow-$93.0M+52.6%

Valuation

See full
Market cap$3B+63.6%

Profitability

See full
Gross margin15.1%-3.8pp
Net margin-7%-7.3pp
FCF margin5.1%-1.7pp

Returns & leverage

See full
Return on equity-105%-107pp
Debt / equity20.6×+12.8×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Chemours’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemours's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemours's additional paid-in capital?
Chemours (CC) reported additional paid-in capital of $1.08B in Q1 2026.
How has Chemours's additional paid-in capital changed year-over-year?
Chemours's additional paid-in capital increased by 2.0% year-over-year, from $1.06B to $1.08B.
What is the long-term trend for Chemours's additional paid-in capital?
Over 5 years (2020 to 2025), Chemours's additional paid-in capital has grown at a 3.8% compound annual growth rate (CAGR), from $890M to $1.07B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.